
Novartis
Novartis is a Swiss-American multinational pharmaceutical corporation. It was founded in 1996. Its headquarters are in Basel. Its chief executive is Vasant Narasimhan. It has 119,418 employees. It won the BigBrotherAwards and 1 more.
- Founded
- 1996
- Headquarters
- Basel
- Industry
- pharmaceutical industry
- Chief executive
- Vasant Narasimhan (2017–)
- Employees
- 119,418
- Country
- Switzerland
All 15 facts, and where they come from
Facts
15 facts · 0 confirmed by two sources · 4 cited · 11 from one source
Where this comes from
Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.
What Wikidata says · copied November 17, 2026 · revision 2534564518
- Described as
- Swiss-American multinational pharmaceutical corporation
- Other names
- Novartis International AG, NVS
- What it is
- business; multinational corporation; public company · 1 reference
- Comes after
- Ciba-Geigy (1999)
- Founded
- 1996
- Headquarters
- Basel · 1 reference
- Country
- Switzerland · 1 reference
- Industry
- pharmaceutical industry; chemical industry · 1 reference
- Chief executive
- Dan Vasella (–2010); Joseph Jimenez (2010–2017)
- Employees
- 119,418
- Awards
- BigBrotherAwards (2007) · 1 reference; Public Eye Swiss Award (2007)
- Official website
- http://www.novartis.com/
- Wikipedias with a page
- 46
Wikidata item Q507154 (wikidata.org/wiki/Q507154), public domain (CC0). Copied 2026-11-17.
What Wikipedia says · copied November 17, 2026 · revision 1385479218
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; produced by Sandoz since 2023), terbinafine (Lamisil), deferasirox (Exjade), and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes (new skills).
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca, which also divested its agrochemical business. The new company also acquired a series of acquisitions in order to strengthen its core businesses.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Biotechnology Innovation Organization (BIO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the Pharmaceutical Research and Manufacturers of America (PhRMA). Novartis is the third most valuable pharmaceutical company in Europe, after Novo and Roche.
From the Wikipedia article “Novartis” (en.wikipedia.org/wiki/Novartis), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied 2026-11-17; not changed.
Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.
Picture: Alexandre Prevot from Nancy, France, via Wikimedia Commons · CC BY-SA 2.0

